Added to YB: 2025-09-15
Pitch date: 2025-09-11
ALAFY.PA [neutral]
AFYREN SAS
+6.15%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids.
Market Cap
EUR 74.7M
Pitch Price
EUR 2.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.89
P/E
-6.50
EV/Sales
18.41
Sector
Chemicals
Category
growth
Afyren (ALAFY France): building momentum as industrial ramp-up takes shape
ALAFY.PA (quick overview): Industrial biotech transitioning from dev to scale-up. Neoxy plant started continuous production, targeting 20k tonnes capacity & mid-teens millions EBITDA. Order book covers several years. Plans 2 more plants. High-risk/reward with pathway to €150M revenue if model replicates successfully.
Read full article (2 min)